MFG
HUMA icon

Merit Financial Group’s Humacyte HUMA Stock Holding History

Merit Financial Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2K Buy
52,812
+10,854
+26% +$10.1K ﹤0.01% 2300
2026
Q1 		$25.5K Buy
41,958
+23,943
+133% +$24.9K ﹤0.01% 2093
2025
Q4 		$17.3K Sell
18,015
-9,653
-35% -$13.7K ﹤0.01% 1950
2025
Q3 		$48.1K Buy
27,668
+1,589
+6% +$3.11K ﹤0.01% 1773
2025
Q2 		$54.5K Buy
26,079
+12,513
+92% +$24K ﹤0.01% 1666
2025
Q1 		$23.1K Buy
+13,566
New +$50.9K ﹤0.01% 1384

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Merit Financial Group's HUMA Position: Q2 2026 in Review

Merit Financial Group increased its Humacyte (HUMA) stake by 26% in Q2 2026, buying an estimated $10.1K and bringing the position to 52,812 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2300.

Merit Financial Group first reported a position in HUMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $54.5K in Q2 2025. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Merit Financial Group held 52,812 shares of Humacyte worth $41.2K as of Q2 2026.
  • Merit Financial Group bought 10,854 Humacyte shares in Q2 2026, an estimated $10.1K.
  • Humacyte made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2300 holding.
  • Merit Financial Group first reported a position in Humacyte in Q1 2025 and has held it in 6 quarters since.
  • Merit Financial Group's Humacyte position peaked at $54.5K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.